'On Saturday, February 23, 2008, after more than a decade of hard work, Dr. John Halpern conducted the first experimental session in his study of MDMA-assisted psychotherapy in twelve subjects with treatment-resistant anxiety associated with advanced-stage cancer. Dr. Halpern is also conducting a major five-year NIDA-funded study into the neurocognitive risks of heavy use of Ecstasy, enhancing his ability to balance the risks and benefits of MDMA.' (Multidisciplinary Association for Psychedelic Studies website).
media-underground.net